Virtual reality (VR) shows promise in the application of healthcare and because it presents
patients an immersive, often entertaining, approach to accomplish the goal of improvement …

During the past 25 years, botulinum toxin type A (BoNT-A) has become the most widely used
medical intervention in children with cerebral palsy. In this review we consider the gaps in …

Crouch gait, a common walking pattern in individuals with cerebral palsy, is characterized by
excessive flexion of the hip and knee. Many subjects with crouch gait experience knee pain …

Non‐technical summary Muscle spasticity, due to an upper motoneuron lesion, often leads
to muscle contractures that limit range of motion and cause increased muscle stiffness …

Cerebral palsy (CP) is caused by a static lesion to the brain occurring in utero or up to the
first 2 years of life; it often manifests as musculoskeletal impairments and movement …

Background: Hip displacement is considered to be common in children with cerebral palsy
but the reported incidence and the proposed risk factors vary widely. Knowledge regarding …

An interdisciplinary European group of clinical experts in the field of movement disorders
and experienced Botulinum toxin users has updated the consensus for the use of Botulinum …

Treatment of Cerebral Palsy and Motor Delay is a highly practical, easy-to-read resource for
all paediatric practitioners and students working with the developmental abilities and …

In this study we assessed the distribution of spasticity, range of motion (ROM) deficits, and
selective motor control problems in children with cerebral palsy (CP), and examined how …

The Gross Motor Function Classification System (GMFCS) was developed in response to the
need to have a standardized system to measure the 'severity of movement disability'in …